Comparative accuracy of cardiovascular risk prediction methods in primary care patients
暂无分享,去创建一个
W A Bartlett | J Walker | F. Game | W. Bartlett | A. Jones | T. Marshall | A F Jones | C Jewkes | F L Game | T Marshall | G R Bayly | J. Walker | C. Jewkes | G. Bayly
[1] J. McCormack,et al. Primary prevention of heart disease and stroke: a simplified approach to estimating risk of events and making drug treatment decisions. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[2] Tunstall-Pedoe. "Absolute" is inappropriate for quantitative risk estimation , 2000, BMJ.
[3] R. Jackson. Guidelines on preventing cardiovascular disease in clinical practice , 2000, BMJ : British Medical Journal.
[4] J. Norrie,et al. Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods , 2000, BMJ : British Medical Journal.
[5] G. Mancia,et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.
[6] L. Ramsay,et al. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table , 1996, The Lancet.
[7] L. Simons,et al. Management of hyperlipidaemia. , 1987, Drug and therapeutics bulletin.
[8] L. Ramsay,et al. Lipid-lowering for prevention of coronary heart disease: what policy now? , 1996, Clinical science.
[9] K. Anderson,et al. Cardiovascular disease risk profiles. , 1991, American heart journal.
[10] L. Poston,et al. British Hypertension Society guidelines for hypertension management 1999: summary , 1999, BMJ.
[11] P. Macfarlane,et al. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). , 1998, Circulation.
[12] Petros Nihoyannopoulos,et al. Joint British recommendations on prevention of coronary heart disease in clinical practice , 1998, Heart.
[13] Joint British recommendations on prevention of coronary heart disease in clinical practice: summary , 2001, BMJ : British Medical Journal.
[14] I. U. Haq,et al. Coronary and cardiovascular risk estimation for primary prevention:validation of a new Sheffield table in the 1995 Scottish health survey population , 2000, BMJ : British Medical Journal.
[15] D. Sackett,et al. Guidelines for managing raised blood pressure , 1996, BMJ.
[16] K. Pyörälä,et al. Management of hyperlipidaemia. Why, when and how to treat. , 1997, European Heart Journal.
[17] B. Swinburn. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand. , 1996, The New Zealand medical journal.
[18] Patrick Vallance,et al. A simple computer program for guiding management of cardiovascular risk factors and prescribing , 1999, BMJ.
[19] AF Jones. Statins and hypercholesterolaemia: UK Standing Medical Advisory Committee guidelines , 1997, The Lancet.
[20] A. Jones,et al. Laboratory‐based calculation of coronary heart disease risk in a hospital diabetic clinic , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[21] D. Bhatnagar,et al. Indications for cholesterol-lowering medication: comparison of risk-assessment methods , 1999, The Lancet.
[22] J. French,et al. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study , 2000, BMJ : British Medical Journal.
[23] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.